David Bohr

David Bohr is an experienced clinical operations head with a demonstrated history of accelerating and directing early phase oncology clinical development. Skilled in trial design and management, CRO oversight, GXP compliance, and regulatory filing. David was previously a Clinical Trial Leader at Novartis Institutes for Biomedical Research. David holds an MBA from Boston University Questrom School of Business; a master’s degree in Genomics and Molecular Biology from New York University; a master’s degree in Public Health from Boston University.